Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Goretti Duran, Raquel Cruz, Ana Rita Simoes, Francisco Barros, José María Giráldez, Beatriz Bernárdez, Urbano Anido, Sonia Candamio, Rafael López-López, Ángel Carracedo & María Jesús Lamas. (2020) Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?. Journal of Chemotherapy 32:6, pages 310-322.
Read now
Read now
Thangirala Sudha, Dhruba J Bharali, Murat Yalcin, Noureldien HE Darwish, Melis Debreli Coskun, Kelly A Keating, Hung-Yun Lin, Paul J Davis & Shaker A Mousa. (2017) Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. International Journal of Nanomedicine 12, pages 1305-1315.
Read now
Read now
Xiwei Yu, Jiahui Hou, Yijie Shi, Chang Su & Liang Zhao. (2016) Preparation and characterization of novel chitosan–protamine nanoparticles for nucleus-targeted anticancer drug delivery. International Journal of Nanomedicine 11, pages 6035-6046.
Read now
Read now
Nicholas Li-Xun Syn, Wei-Peng Yong, Soo-Chin Lee & Boon-Cher Goh. (2015) Genetic factors affecting drug disposition in Asian cancer patients. Expert Opinion on Drug Metabolism & Toxicology 11:12, pages 1879-1892.
Read now
Read now
Godefridus J Peters & Richard J Honeywell. (2015) Drug transport and metabolism of novel anticancer drugs. Expert Opinion on Drug Metabolism & Toxicology 11:5, pages 661-663.
Read now
Read now
Articles from other publishers (29)
Mandana Hasanzad, Negar Sarhangi, Hamid Reza Aghaei Meybodi & Shekoufeh Nikfar. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
467
491
.
Antonin Schmitt, Bernard Royer, Romain Boidot, Joseph Berthier & François Ghiringhelli. (2023) Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency. Frontiers in Oncology 13.
Crossref
Crossref
Juliana Carla Gomes Rodrigues, Marianne Rodrigues Fernandes, André Maurício Ribeiro-dos-Santos, Gilderlanio Santana de Araújo, Sandro José de Souza, João Farias Guerreiro, Ândrea Ribeiro-dos-Santos, Paulo Pimentel de Assumpção, Ney Pereira Carneiro dos Santos & Sidney Santos. (2022) Pharmacogenomic Profile of Amazonian Amerindians. Journal of Personalized Medicine 12:6, pages 952.
Crossref
Crossref
Giacomo Miserocchi, Chiara Spadazzi, Sebastiano Calpona, Francesco De Rosa, Alice Usai, Alessandro De Vita, Chiara Liverani, Claudia Cocchi, Silvia Vanni, Chiara Calabrese, Massimo Bassi, Giovanni De Luca, Giuseppe Meccariello, Toni Ibrahim, Marco Schiavone & Laura Mercatali. (2022) Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches. Journal of Personalized Medicine 12:6, pages 854.
Crossref
Crossref
Marianne Rodrigues Fernandes, Juliana Carla Gomes Rodrigues, Elizabeth Ayres Fragoso Dobbin, Lucas Favacho Pastana, Danielle Feio da Costa, Williams Fernandes Barra, Antônio André Conde Modesto, Paula Baraúna de Assumpção, Artur Luiz da Costa Silva, Sidney Emanuel Batista dos Santos, Rommel Mario Rodriguez Burbano, Paulo Pimentel de Assumpção & Ney Pereira Carneiro dos Santos. (2021) Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon. Cancer Chemotherapy and Pharmacology 88:5, pages 837-844.
Crossref
Crossref
Loredana G. Marcu & David C. Marcu. (2021) Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy. Journal of Personalized Medicine 11:11, pages 1094.
Crossref
Crossref
Artsiom Klimko, Cristian G Tieranu, Andrei O Olteanu, Carmen M Preda & Elena M Ionescu. (2021) Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review. Cureus.
Crossref
Crossref
Anna Florczak, Inga Grzechowiak, Tomasz Deptuch, Kamil Kucharczyk, Alicja Kaminska & Hanna Dams-Kozlowska. (2020) Silk Particles as Carriers of Therapeutic Molecules for Cancer Treatment. Materials 13:21, pages 4946.
Crossref
Crossref
Zhao Qingwei, Hong Dongsheng, Lv Duo, Wang Youlei, Yu Songxia, Ye Ziqi & Li Lanjuan. (2020) Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients. Frontiers in Oncology 10.
Crossref
Crossref
Eiji Hishinuma, Evelyn Gutiérrez Rico & Masahiro Hiratsuka. (2020) In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase. Journal of Clinical Medicine 9:8, pages 2342.
Crossref
Crossref
Erin Pleasance, Emma Titmuss, Laura Williamson, Harwood Kwan, Luka Culibrk, Eric Y. Zhao, Katherine Dixon, Kevin Fan, Reanne Bowlby, Martin R. Jones, Yaoqing Shen, Jasleen K. Grewal, Jahanshah Ashkani, Kathleen Wee, Cameron J. Grisdale, My Linh Thibodeau, Zoltan Bozoky, Hillary Pearson, Elisa Majounie, Tariq Vira, Reva Shenwai, Karen L. Mungall, Eric Chuah, Anna Davies, Mya Warren, Caralyn Reisle, Melika Bonakdar, Gregory A. Taylor, Veronika Csizmok, Simon K. Chan, Zusheng Zong, Steve Bilobram, Amir Muhammadzadeh, Darryl D’Souza, Richard D. Corbett, Daniel MacMillan, Marcus Carreira, Caleb Choo, Dustin Bleile, Sara Sadeghi, Wei Zhang, Tina Wong, Dean Cheng, Scott D. Brown, Robert A. Holt, Richard A. Moore, Andrew J. Mungall, Yongjun Zhao, Jessica Nelson, Alexandra Fok, Yussanne Ma, Michael K. C. Lee, Jean-Michel Lavoie, Shehara Mendis, Joanna M. Karasinska, Balvir Deol, Ana Fisic, David F. Schaeffer, Stephen Yip, Kasmintan Schrader, Dean A. Regier, Deirdre Weymann, Stephen Chia, Karen Gelmon, Anna Tinker, Sophie Sun, Howard Lim, Daniel J. Renouf, Janessa Laskin, Steven J. M. Jones & Marco A. Marra. (2020) Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes. Nature Cancer 1:4, pages 452-468.
Crossref
Crossref
Dimitra Ioanna Lampropoulou, Konstantinos Laschos, Anna-Lea Amylidi, Ariadni Angelaki, Nikolaos Soupos, Sotirios Boumpoucheropoulos, Eirini Papadopoulou, Evgenia Nanou, Vasilios Zidianakis, George Nasioulas, George Fildissis & Gerasimos Aravantinos. (2019) Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?. Journal of Oncology Pharmacy Practice 26:3, pages 747-753.
Crossref
Crossref
Taro Shiga & Makoto Hiraide. (2020) Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines. Current Treatment Options in Oncology 21:4.
Crossref
Crossref
Seid Hamzic, Dominic Kummer, Tanja K. Froehlich, Markus Joerger, Stefan Aebi, Claire Palles, Ian Thomlinson, Didier Meulendijks, Jan H.M. Schellens, Xandra García-González, Luis A. López-Fernández, Ursula Amstutz & Carlo R. Largiadèr. (2020) Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. Pharmacological Research 152, pages 104594.
Crossref
Crossref
Marzia Del Re, Saverio Cinieri, Angela Michelucci, Stefano Salvadori, Fotios Loupakis, Marta Schirripa, Chiara Cremolini, Stefania Crucitta, Cecilia Barbara, Angelo Di Leo, Tiziana Pia Latiano, Filippo Pietrantonio, Samantha Di Donato, Paolo Simi, Alessandro Passardi, Filippo De Braud, Giuseppe Altavilla, Claudio Zamagni, Roberto Bordonaro, Alfredo Butera, Evaristo Maiello, Carmine Pinto, Alfredo Falcone, Valentina Mazzotti, Riccardo Morganti & Romano Danesi. (2019) DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients. The Pharmacogenomics Journal 19:6, pages 556-563.
Crossref
Crossref
Tao Duan, Zhuobin Xu, Fumou Sun, Yang Wang, Juan Zhang, Chen Luo & Min Wang. (2019) HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. Biomedicine & Pharmacotherapy 117, pages 109121.
Crossref
Crossref
Pauline Macaire, Katarzyna Morawska, Julie Vincent, Valérie Quipourt, Sophie Marilier, François Ghiringhelli, Leila Bengrine-Lefevre & Antonin Schmitt. (2019) Therapeutic drug monitoring as a tool to optimize 5-FU–based chemotherapy in gastrointestinal cancer patients older than 75 years. European Journal of Cancer 111, pages 116-125.
Crossref
Crossref
Jun Hua Chong & Arjun K Ghosh. (2019) Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions. Interventional Cardiology Review 14:2, pages 89-94.
Crossref
Crossref
Margherita Ratti, Jens Claus Hahne, Laura Toppo, Emanuela Castelli, Fausto Petrelli, Rodolfo Passalacqua, Sandro Barni, Gianluca Tomasello & Michele Ghidini. (2019) Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Therapeutic Advances in Medical Oncology 11, pages 175883591985395.
Crossref
Crossref
Mira Zurayk, Yi-Kong Keung, David Yu & Eddie HL Hu. (2017) Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature. Journal of Oncology Pharmacy Practice 25:1, pages 234-238.
Crossref
Crossref
Virginia Wotring. 2019. Principles of Clinical Medicine for Space Flight. Principles of Clinical Medicine for Space Flight
815
840
.
Yvonne L. Chao & Carey K. Anders. (2018) TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5–Fluorouracil-Based Chemotherapy. Clinical Breast Cancer 18:3, pages e301-e304.
Crossref
Crossref
Xiao-Yun Liu, Fei-Ran Zhang, Jin-Yan Shang, Ying-Ying Liu, Xiao-Fei Lv, Jia-Ni Yuan, Ting-Ting Zhang, Kai Li, Xiao-Chun Lin, Xiu Liu, Qingqing Lei, Xiao-Dong Fu, Jia-Guo Zhou & Si-Jia Liang. (2018) Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity. Cell Death & Disease 9:6.
Crossref
Crossref
N. O. Elander, K. Aughton, P. Ghaneh, J. P. Neoptolemos, D. H. Palmer, T. F. Cox, F. Campbell, E. Costello, C. M. Halloran, J. R. Mackey, A. G. Scarfe, J. W. Valle, A. C. McDonald, R. Carter, N. C. Tebbutt, D. Goldstein, J. Shannon, C. Dervenis, B. Glimelius, M. Deakin, R. M. Charnley, A. Anthoney, M. M. Lerch, J. Mayerle, A. Oláh, M. W. Büchler & W. Greenhalf. (2018) Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer 118:8, pages 1084-1088.
Crossref
Crossref
Nabil F. Saba, Mayur D. Mody, Elaine S. Tan, Harpaul S. Gill, Alessandra Rinaldo, Robert P. Takes, Primož Strojan, Dana M. Hartl, Jan B. Vermorken, Missak HaigentzJr.Jr. & Alfio Ferlito. (2017) Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy. Critical Reviews in Oncology/Hematology 115, pages 50-58.
Crossref
Crossref
Thangirala Sudha, Dhruba J Bharali, Murat Yalcin, Noureldien HE Darwish, Melis Debreli Coskun, Kelly A Keating, Hung-Yun Lin, Paul J Davis & Shaker A Mousa. (2017) Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac. Nanomedicine 12:3, pages 195-205.
Crossref
Crossref
Yan Lou, Qian Wang, Jinqi Zheng, Haihong Hu, Lin Liu, Dongsheng Hong & Su Zeng. (2016) Possible Pathways of Capecitabine-Induced Hand–Foot Syndrome. Chemical Research in Toxicology 29:10, pages 1591-1601.
Crossref
Crossref
Valéria Grobárová, Karel Vališ, Pavel Talacko, Barbora Pavlů, Lucie Hernychová, Jana Nováková, Eva Stodůlková, Miroslav Flieger, Petr Novák & Jan Černý. (2016)
Quambalarine B, a Secondary Metabolite from
Quambalaria cyanescens
with Potential Anticancer Properties
. Journal of Natural Products 79:9, pages 2304-2314.
Crossref
Crossref
Jared M Campbell, Emma Bateman, Micah DJ Peters, Joanne M Bowen, Dorothy M Keefe & Matthew D Stephenson. (2016) Fluoropyrimidine and platinum toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses. Pharmacogenomics 17:4, pages 435-451.
Crossref
Crossref